Related Experiment Video
Updated: May 24, 2026
Inguinal Subcutaneous White Adipose Tissue (ISWAT) Transplantation Model of Murine Islets
Published on: February 16, 2020
Encapsulated islets transplantation: Past, present and future
Naoaki Sakata1, Shoichiro Sumi, Gumpei Yoshimatsu
1Naoaki Sakata, Gumpei Yoshimatsu, Shinichi Egawa, Michiaki Unno, Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8574, Japan.
Encapsulated islets offer a promising solution for diabetes treatment by shielding transplanted cells and reducing the need for immunosuppressants. This bio-artificial pancreas technology addresses donor limitations and minimizes drug side effects for improved patient outcomes.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Immunology
Background:
- Islet transplantation is a potential treatment for severe diabetes, aiming to prevent hypoglycemia and diabetic complications.
- Current challenges include limited donor availability and the adverse effects of long-term immunosuppression.
Purpose of the Study:
- To explore the potential of encapsulated islets as a viable treatment for diabetes.
- To overcome key obstacles in islet transplantation, such as immune rejection and donor scarcity.
Main Methods:
- Development of semi-permeable polymer membranes for islet encapsulation.
- Utilizing encapsulation to achieve immune-isolation of transplanted islets.
- Investigating the use of xenogeneic islets and stem cells for encapsulation.
Main Results:
- Encapsulation protects islets from the recipient's immune system, enabling immune-isolation.
- This technique allows for the use of diverse cell sources, including xenogeneic islets and stem cells, addressing donor limitations.
- Encapsulation significantly reduces or eliminates the need for chronic immunosuppressant drug administration, mitigating associated side effects.
Conclusions:
- Encapsulated islets, or bio-artificial pancreas, represent a significant advancement in diabetes therapy.
- This technology holds the potential to resolve major challenges in islet transplantation, paving the way for clinical applications.
- Novel encapsulated islet systems are advancing towards clinical testing, offering hope for improved diabetes management.
